Sangamo Therapeutics
SGMO
$0.49
Share price
-5.99%
Change (1 day)
-69.49%
Change (1 year)
P/S ratio for Sangamo Therapeutics (SGMO)
P/S ratio as of April 2024 (TTM): 0.5606
According to Sangamo Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.560621. At the end of 2023 the company had a P/S ratio of 0.5467.
P/S ratio history for Sangamo Therapeutics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.5467 | -88.17% |
| 2022 | 4.62 | -53.15% |
| 2021 | 9.87 | -47.15% |
| 2020 | 18.7 | 97.06% |
| 2019 | 9.48 | -31.78% |
| 2018 | 13.9 | -63.36% |
| 2017 | 37.9 | 241.21% |
| 2016 | 11.1 | -31.62% |
| 2015 | 16.2 | -29.06% |
| 2014 | 22.9 | -36.08% |
| 2013 | 35.8 | 143.29% |
| 2012 | 14.7 | 1.97% |
| 2011 | 14.4 | -0.28% |
| 2010 | 14.5 | 20.63% |
| 2009 | 12.0 | 36.26% |
| 2008 | 8.81 | -84.73% |
| 2007 | 57.7 | 96.7% |
| 2006 | 29.3 | -40.88% |
| 2005 | 49.6 | -56.97% |
| 2004 | 115 | 117.86% |
| 2003 | 52.9 | 208.67% |
| 2002 | 17.1 | -63.37% |
| 2001 | 46.8 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.78 | 573.44% | 🇺🇸 USA |
 Amgen AMGN | 5.00 | 791.00% | 🇺🇸 USA |
 Biogen BIIB | 2.82 | 402.25% | 🇺🇸 USA |
 Dow DOW | 0.8963 | 59.87% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.04 | 442.72% | 🇺🇸 USA |
 Merck MRK | 5.28 | 841.25% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | 10.0 | 1,690.84% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 7.07 | 1,160.30% | 🇺🇸 USA |